Showing results (141-150 of 199) with videos related to

Sort By:
Pageof 20
Cancer Chemotherapy and Pharmacology|August 21, 2015
A first-in-human phase I and pharmacokinetic study of CP-4126 (CO-101), a nucleoside analogue, in patients with advanced solid tumoursB Venugopal, A Awada, T R J Evans, et al.
Neurosciences (Riyadh, Saudi Arabia)|August 28, 2013
Diabetic neuropathy. Correlation with other diabetic microvascular complicationsSami A Bashi, Salem D Alsuwaidan, Adnan A Awada, et al.
AJNR. American Journal of Neuroradiology|April 10, 2007
Acute Korsakoff-like amnestic syndrome resulting from left thalamic infarction following a right hippocampal hemorrhageR Rahme, R Moussa, A Awada, et al.
Medical Oncology (Northwood, London, England)|July 8, 2011
Maximising the duration of disease control in metastatic renal cell carcinoma with targeted agents: an expert agreementC Porta, G Tortora, C Linassier, et al.
Anti-Cancer Drugs|May 29, 2004
Prolonged schedule of temozolomide (Temodal) plus liposomal doxorubicin (Caelyx) in advanced solid cancersA Awada, T Gil, F Sales, et al.
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|April 15, 2008
Neurological disorders in renal transplant recipientsG Al Ghamdi, A Awada, D Z Tanimu, et al.
IEEE Transactions on Bio-Medical Engineering|September 15, 1998
Effect of conductivity uncertainties and modeling errors on EEG source localization using a 2-D modelK A Awada, D R Jackson, S B Baumann, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2003
An EORTC-ECSG phase I study of LU 79553 administered every 21 or 42 days in patients with solid tumoursA Awada, R Thödtmann, M J Piccart, et al.
Clinical and Experimental Dermatology|November 29, 2005
High serum galectin-3 in advanced melanoma: preliminary resultsP Vereecken, K Zouaoui Boudjeltia, C Debray, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 18, 2010
Heterogeneity of metabolic response to systemic therapy in metastatic breast cancer patientsV Huyge, C Garcia, J Alexiou, et al.
Pageof 20